Skip to main content
Erschienen in: Journal of Assisted Reproduction and Genetics 11/2013

01.11.2013 | Assisted Reproduction Technologies

Human chorionic gonadotropin levels are equally predictive for pregnancy outcome after fresh and vitrified-warmed blastocyst transfer

verfasst von: Milan Reljič, Jure Knez, Veljko Vlaisavljević

Erschienen in: Journal of Assisted Reproduction and Genetics | Ausgabe 11/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of the present study was to evaluate if the live birth predictive values of β-hCG levels differ in fresh and vitrified-warmed blastocyst transfer cycles.

Methods

In the retrospectively designed study, 775 cycles with positive β-hCG values 13 days after fresh blastocyst transfer (fresh ET; n = 568) or vitrified-warmed blastocyst transfer (FET; n = 207) were selected for analysis. Average β-hCG levels stratified according to pregnancy outcome (biochemical pregnancy, spontaneous abortion, ectopic pregnancy, and singleton or twin birth) were compared between fresh ET and FET cycles. To determine the optimal sensitivity and specificity of β-hCG levels for live birth prediction, a ROC curve was constructed. Fisher’s exact test was used to compare the positive predictive values (PPV).

Results

Average β-hCG levels stratified according to pregnancy outcome were not statistically different between fresh ET and FET cycles. In fresh ET and in FET group, the β-hCG levels were significantly higher in pregnancies resulting in live birth compared to non-viable pregnancies (1,035 vs. 462 IU/L, p < 0.001 and 968 vs. 411 IU/L, p < 0.001). Optimal cut-off level for live birth prediction was 495 IU/L (sensitivity 83.0 %, specificity 71.8 %) after ET and 527 IU/L (sensitivity 80.0 % and specificity 76.6 %) after FET. The PPV for live birth rate in the groups after ET and FET were 90.6 % and 84.9 % respectively, without statistically significant difference (p > 0.05).

Conclusion

Beta-hCG levels after fresh and vitrified-warmed blastocyst transfer are equally predictive for pregnancy outcome. Clinicians can be encouraged to interpret β-hCG results in the same manner.
Literatur
1.
Zurück zum Zitat Lawler CC, Budrys NM, Rodgers AK, Holden A, Brzyski RG, Schenken RS. Serum beta human chorionic gonadotropin levels can inform outcome counseling after in vitro fertilization. Fertil Steril. 2011;96:505–7.PubMedCrossRef Lawler CC, Budrys NM, Rodgers AK, Holden A, Brzyski RG, Schenken RS. Serum beta human chorionic gonadotropin levels can inform outcome counseling after in vitro fertilization. Fertil Steril. 2011;96:505–7.PubMedCrossRef
2.
Zurück zum Zitat Ogawa M, Takamatsu K, Horiguchi F. Evaluation of factors associated with the anxiety and depression of female infertility patients. Biopsychosoc Med. 2011;5:15.PubMedCrossRef Ogawa M, Takamatsu K, Horiguchi F. Evaluation of factors associated with the anxiety and depression of female infertility patients. Biopsychosoc Med. 2011;5:15.PubMedCrossRef
3.
Zurück zum Zitat Aarts JW, Huppelschoten AG, van Empel IW. How patient-centered care relates to patients’ quality of life and distress: a study in 427 women experiencing infertility. Hum Reprod. 2012;27:488–95.PubMedCrossRef Aarts JW, Huppelschoten AG, van Empel IW. How patient-centered care relates to patients’ quality of life and distress: a study in 427 women experiencing infertility. Hum Reprod. 2012;27:488–95.PubMedCrossRef
4.
Zurück zum Zitat Dor J, Rudak E, Rotmench S, Levran D, Blankstein J, Lusky A, et al. The role of early post-implantation beta-HCG levels in the outcome of pregnancies following in-vitro fertilization. Hum Reprod. 1988;3:663–7.PubMed Dor J, Rudak E, Rotmench S, Levran D, Blankstein J, Lusky A, et al. The role of early post-implantation beta-HCG levels in the outcome of pregnancies following in-vitro fertilization. Hum Reprod. 1988;3:663–7.PubMed
5.
Zurück zum Zitat Ertzeid G, Tanbo T, Dale PO, et al. Human chorionic gonadotropin levels in successful implantations after assisted reproduction techniques. Gynecol Endocrinol. 2000;14:258–63.PubMedCrossRef Ertzeid G, Tanbo T, Dale PO, et al. Human chorionic gonadotropin levels in successful implantations after assisted reproduction techniques. Gynecol Endocrinol. 2000;14:258–63.PubMedCrossRef
6.
Zurück zum Zitat Homan G, Brown S, Moran J, Homan S, Kerin J. Human chorionic gonadotropin as a predictor of outcome in assisted reproductive technology pregnancies. Fertil Steril. 2000;73:270–4.PubMedCrossRef Homan G, Brown S, Moran J, Homan S, Kerin J. Human chorionic gonadotropin as a predictor of outcome in assisted reproductive technology pregnancies. Fertil Steril. 2000;73:270–4.PubMedCrossRef
7.
Zurück zum Zitat Kathiresan ASQ, Cruz-Almeida Y, Barrionuevo MJ, et al. Prognostic value of beta-human chorionic gonadotropin is dependent on day of embryo transfer during in vitro fertilization. Fertil Steril. 2011;96:1362–6.PubMedCrossRef Kathiresan ASQ, Cruz-Almeida Y, Barrionuevo MJ, et al. Prognostic value of beta-human chorionic gonadotropin is dependent on day of embryo transfer during in vitro fertilization. Fertil Steril. 2011;96:1362–6.PubMedCrossRef
8.
Zurück zum Zitat Kumbak B. Serum oestradiol and β-hCG measurements after day 3 or 5 embryo transfers in interpreting pregnancy outcome. Reprod Biomed Online. 2006;13:459–64.PubMedCrossRef Kumbak B. Serum oestradiol and β-hCG measurements after day 3 or 5 embryo transfers in interpreting pregnancy outcome. Reprod Biomed Online. 2006;13:459–64.PubMedCrossRef
9.
Zurück zum Zitat Poikkeus P, Hiilesmaa V, Tiitinen A. Serum HCG 12 days after embryo transfer in predicting pregnancy outcome. Hum Reprod. 2002;17:1901–5.PubMedCrossRef Poikkeus P, Hiilesmaa V, Tiitinen A. Serum HCG 12 days after embryo transfer in predicting pregnancy outcome. Hum Reprod. 2002;17:1901–5.PubMedCrossRef
10.
Zurück zum Zitat Sugantha SE, Webster S, Sundar E, Lenton EA. Predictive value of plasma human chorionic gonadotrophin following assisted conception treatment. Hum Reprod. 2000;15:469–73.PubMedCrossRef Sugantha SE, Webster S, Sundar E, Lenton EA. Predictive value of plasma human chorionic gonadotrophin following assisted conception treatment. Hum Reprod. 2000;15:469–73.PubMedCrossRef
11.
Zurück zum Zitat Urbancsek J, Hauzman E, Fedorcsak P, Halmos A, Devenyi N, Papp Z. Serum human chorionic gonadotropin measurements may predict pregnancy outcome and multiple gestation after in vitro fertilization. Fertil Steril. 2002;78:540–2.PubMedCrossRef Urbancsek J, Hauzman E, Fedorcsak P, Halmos A, Devenyi N, Papp Z. Serum human chorionic gonadotropin measurements may predict pregnancy outcome and multiple gestation after in vitro fertilization. Fertil Steril. 2002;78:540–2.PubMedCrossRef
12.
Zurück zum Zitat Zhang X, Barnes R, Confino E, Milad M, Puscheck E, Kazer RR. Delay of embryo transfer to day 5 results in decreased initial serum beta-human chorionic gonadotropin levels. Fertil Steril. 2003;80:1359–63.PubMedCrossRef Zhang X, Barnes R, Confino E, Milad M, Puscheck E, Kazer RR. Delay of embryo transfer to day 5 results in decreased initial serum beta-human chorionic gonadotropin levels. Fertil Steril. 2003;80:1359–63.PubMedCrossRef
13.
Zurück zum Zitat Orasanu B. Effects of culture medium on HCG concentrations and their value in predicting successful IVF outcome. Reprod Biomed Online. 2006;12:590–8.PubMedCrossRef Orasanu B. Effects of culture medium on HCG concentrations and their value in predicting successful IVF outcome. Reprod Biomed Online. 2006;12:590–8.PubMedCrossRef
14.
Zurück zum Zitat Morse CB, Barnhart KT, Sammel MD, Prochaska EC, Dokras A, Coutifaris C. Early rise in hCG as a marker of placentation: a slow rise may predict low birth weight in ART;2011. Oral Presentation, American Society for Reproductive Medicine, Orlando, FL, October Morse CB, Barnhart KT, Sammel MD, Prochaska EC, Dokras A, Coutifaris C. Early rise in hCG as a marker of placentation: a slow rise may predict low birth weight in ART;2011. Oral Presentation, American Society for Reproductive Medicine, Orlando, FL, October
15.
Zurück zum Zitat Vlaisavljević V, Kovačič B, Gavrić-Lovrec V, Reljič M. Simplification of the clinical phase of IVF and ICSI treatment in programmed cycles. Int J Gynaecol Obstet. 2000;69:35–42. Vlaisavljević V, Kovačič B, Gavrić-Lovrec V, Reljič M. Simplification of the clinical phase of IVF and ICSI treatment in programmed cycles. Int J Gynaecol Obstet. 2000;69:35–42.
16.
Zurück zum Zitat Kovačič B, Vlaisavljević V, Reljič M, Čižek-Sajko M. Developmental capacity of different morphological types of day 5 human morulae and blastocysts. Reprod Biomed Online. 2004;8:687–94.PubMedCrossRef Kovačič B, Vlaisavljević V, Reljič M, Čižek-Sajko M. Developmental capacity of different morphological types of day 5 human morulae and blastocysts. Reprod Biomed Online. 2004;8:687–94.PubMedCrossRef
17.
Zurück zum Zitat Kovačič B, Vlaisavljević V. Importance of blastocyst morphology in selection for transfer. In Advances in embryo transfer. Bin Wu, Rijeka, Intech, 2012, 161–77 Kovačič B, Vlaisavljević V. Importance of blastocyst morphology in selection for transfer. In Advances in embryo transfer. Bin Wu, Rijeka, Intech, 2012, 161–77
18.
Zurück zum Zitat Khalaf Y, El-Toukhy T. The search for a practice model to reduce miscarriage after assisted reproduction. Reprod Biomed Online. 2011;23:695–6.PubMedCrossRef Khalaf Y, El-Toukhy T. The search for a practice model to reduce miscarriage after assisted reproduction. Reprod Biomed Online. 2011;23:695–6.PubMedCrossRef
19.
Zurück zum Zitat Ku PY, Lee RK, Lin SY, Lin MH, Hwu YM. Comparison of the clinical outcomes between fresh blastocyst and vitrified-thawed blastocyst transfer. J Assist Reprod Genet. 2012;29:1353–6.PubMedCrossRef Ku PY, Lee RK, Lin SY, Lin MH, Hwu YM. Comparison of the clinical outcomes between fresh blastocyst and vitrified-thawed blastocyst transfer. J Assist Reprod Genet. 2012;29:1353–6.PubMedCrossRef
20.
Zurück zum Zitat Dumoulin JC, Land JA, Van Montfoort AP, Nelissen EC, Coonen E, Derhaag JG, et al. Effect of in vitro culture of human embryos on birthweight of newborns. Hum Reprod. 2010;25:605–12.PubMedCrossRef Dumoulin JC, Land JA, Van Montfoort AP, Nelissen EC, Coonen E, Derhaag JG, et al. Effect of in vitro culture of human embryos on birthweight of newborns. Hum Reprod. 2010;25:605–12.PubMedCrossRef
21.
Zurück zum Zitat Kolibianakis EM, Venetis CA, Tarlatzis BC. Cryopreservation of human embryos by vitrification or slow freezing: which one is better? Curr Opin Obstet Gynecol. 2009;21:270–4.PubMedCrossRef Kolibianakis EM, Venetis CA, Tarlatzis BC. Cryopreservation of human embryos by vitrification or slow freezing: which one is better? Curr Opin Obstet Gynecol. 2009;21:270–4.PubMedCrossRef
Metadaten
Titel
Human chorionic gonadotropin levels are equally predictive for pregnancy outcome after fresh and vitrified-warmed blastocyst transfer
verfasst von
Milan Reljič
Jure Knez
Veljko Vlaisavljević
Publikationsdatum
01.11.2013
Verlag
Springer US
Erschienen in
Journal of Assisted Reproduction and Genetics / Ausgabe 11/2013
Print ISSN: 1058-0468
Elektronische ISSN: 1573-7330
DOI
https://doi.org/10.1007/s10815-013-0099-6

Weitere Artikel der Ausgabe 11/2013

Journal of Assisted Reproduction and Genetics 11/2013 Zur Ausgabe

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.